BRD4 and neoplasm: Several studies demonstrated that miRNA-612 (miR-612) exerts tumor-suppressive effects through targeting multiple anti-apoptotic genes, such as bromodomain-containing protein 4 (BRD4), AKT serine/threonine kinase 2 (AKT2), and NIN1/PSMD8 binding protein 1 homolog (NOB1) [42,43,44].